REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Severin S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Lessors of Real Estate | Lessors of Other Real Estate Property | Restaurants and Other Eating Places
Full name: Severin S.R.O. Profile Updated: July 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Severin S.R.O. is based in Slovakia, with the head office in Malacky. It operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on June 03, 2006. It currently has a total number of 5 - 9 (2025) employees. There was a net sales revenue drop of 5.23% reported in Severin S.R.O.’s latest financial highlights for 2024. Its’ total assets recorded a growth of 8.41%. In 2024, Severin S.R.O.’s net profit margin decreased by 1.52%.

Headquarters
Budovatelska, 8/2512
Malacky; Bratislavsky; Postal Code: 90101

Contact Details: Purchase the Severin S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Severin S.R.O. report to view the information.
Registered Capital:
Purchase the Severin S.R.O. report to view the information.
Financial Auditors:
Purchase the Severin S.R.O. report to view the information.
Incorporation Date:
June 03, 2006
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Severin S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-5.23%▼
Total operating revenue
-7.13%▼
Operating profit (EBIT)
-23.98%▼
EBITDA
-22.24%▼
Net Profit (Loss) for the Period
-29.69%▼
Total assets
8.41%▲
Total equity
-57.4%▼
Operating Profit Margin (ROS)
-1.43%▼
Net Profit Margin
-1.52%▼
Return on Equity (ROE)
15.42%▲
Debt to Equity Ratio
-6.96%▼
Quick Ratio
-2.45%▼
Cash Ratio
-2.2%▼

Similar companies

Dr.Max 100 S.R.O.
 
Lekaren Rpt, S. R. O.
Benu Sk 77, S. R. O.
 
Lekaren Arcus, S.R.O.
Unizdrav Presov, S.R.O.
 
Z&T Pharma S.R.O.
Comorrapharm S.R.O.
 
Benu Sk 41, S.R.O.
Dr.Max 42 S.R.O.
 
Dr.Max 57 S.R.O.
Dr.Max 79 S.R.O.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo